Breast surgery can restore contour, protect fragile tissue, and support recovery after cancer treatment or cosmetic care. According to a study analyzing over 103,000 immediate breast reconstructions in the United States from 2005 to 2022, roughly 86% were implant-based, and the overall 30-day complication rate reached nearly 6%. In St. Louis, MO, and across the country, patients undergoing these procedures may receive mesh to help support an implant, yet the FDA has not approved any surgical mesh for use in breast surgery. Risk varies by product, surgical method, healing pattern, and follow-up care.

Patients have reported persistent pain, swelling, infection, thick scar capsules, and additional operations years after mesh placement. Those facing such complications may consider pursuing a breast mesh lawsuit to explore legal options related to device choice, surgical technique, and informed consent. Clear information helps families ask sharper questions when symptoms appear.

Why Mesh Is Used

Surgeons may place mesh during reconstruction to cradle an implant, define the lower breast fold, or reinforce thin tissue after mastectomy. The concern often centers on disclosure, warnings, and material behavior inside tissue. When complications arise, questions about whether the patient was fully informed before surgery become central to any legal review.

Common Mesh Materials

Breast mesh may be synthetic, biologic, or processed from donated human or animal tissue. Biologic sheets are commonly called acellular dermal matrices. Synthetic products may contain polypropylene or related polymers. Each material integrates differently after implantation. Some soften as healing progresses. Others can contract, wrinkle, harden, or sustain inflammation near nerves, muscles, and implant surfaces.

The Body Reacts

An implantable sheet can trigger a foreign-body response. Immune cells may surround the material, and then fibroblasts lay down collagen. A thin capsule is expected after surgery. The FDA's device safety page notes that no surgical mesh has been cleared or approved for use in breast reconstruction. Problems begin when that capsule becomes dense, tight, or tender. Excess scarring can pull on nerves, restrict chest movement, and distort breast position.

Pain Can Persist

Chronic pain may stem from nerve irritation, inflamed tissue, scar traction, or pressure from an implant pocket. Patients may describe burning, pulling, stabbing, or deep chest soreness. Symptoms can begin early or appear after months of normal healing. Because reconstruction often follows cancer treatment, ongoing discomfort may be mistaken for routine recovery. Persistent pain deserves careful evaluation.

Infection Risks

Mesh can provide a surface where bacteria attach and form biofilm. Antibiotics may control mild infection, but deeper cases sometimes require removing the implanted material. Warning signs include redness, warmth, drainage, fever, tenderness, or rapid swelling. Infection can delay cancer therapy, prolong wound care, and increase the likelihood of another procedure.

Fluid Buildup

Fluid near an implant or mesh is called a seroma. Small pockets may resolve with observation. Larger collections can stretch skin, intensify pain, and increase infection risk. Late swelling should be assessed promptly, particularly with textured implants or unexplained breast changes. Clinicians may order imaging, drain fluid, or send samples for testing.

Scar Tightening

Capsular contracture occurs when scar tissue squeezes an implant. The breast may feel firm, sit higher, look misshapen, or become painful. Surgeons often grade severity from one through four. Advanced contracture may require capsule removal, implant exchange, or reconstruction revision. Mesh can affect how scar tissue forms and where tension develops.

Migration and Folding

Mesh is intended to remain fixed in the surgical pocket. Poor tissue integration, motion, tension, or weak anchoring can allow folding, shifting, or bunching. These changes may create rippling, pressure points, or visible asymmetry. A patient might notice firmness, altered shape, height difference, or discomfort during arm movement.

Repeat Surgery

Long-term injury often becomes visible when revision surgery is needed. Another operation may remove infected material, release scar tissue, drain fluid, or correct deformity. Each procedure carries anesthesia, bleeding, wound, and healing risks. Repeat surgery can also affect employment, caregiving, body image, emotional health, and confidence in medical decisions.

Warning Signs

Patients should report new breast pain, sudden swelling, firmness, drainage, redness, fever, lumps, skin changes, or asymmetry. Symptoms that arise years later still require attention. Operative notes, implant cards, product labels, imaging, and pathology reports can identify what was placed. Early review may limit permanent damage.

Informed Consent

Good consent means more than signing a form. Patients should hear why mesh is being used, whether other options exist, and how removal would work if complications occur. Risk estimates should be direct, balanced, and understandable. That discussion helps people weigh appearance, recovery time, cancer history, surgical burden, and future health needs.

Conclusion

Mesh can play a useful role in breast surgery, but the benefit does not cancel the long-term risk. Pain, infection, seroma, contracture, deformity, and revision surgery can affect health for years. Careful monitoring matters after any implant-based procedure. Patients who notice changes should seek medical advice, gather records, and ask direct questions about materials used. Reliable information gives our families a stronger path toward care, answers, and accountability.